Review

Promoter engineering for the recombinant protein production in prokaryotic systems

  • Received: 20 February 2020 Accepted: 07 April 2020 Published: 08 April 2020
  • Recombinant proteins have an economical value with their utilization in many areas from food industry to pharmaceutical and chemical industry. Therefore, it is of great importance to establish optimum production systems for the proteins of interest. One of the critical steps in protein production is regulation of the gene expression. Promoters are among the key regulatory elements which can directly control the level of recombinant gene expression in a host cell. Thus, a suitable promoter is required for optimum gene expression. Promoter engineering is an innovative approach to find out the best promoter system for the expression of recombinant genes, which influences the overproduction of proteins of interest. In this review, some of the bacterial hosts highly used in recombinant protein production were discussed. Next, the importance of promoters in recombinant gene expression, and promoter engineering for enhanced protein production were described. Utilization of double promoter systems was highlighted as one of the successful techniques in overproduction of recombinant proteins. Increment in the variety and availability of the novel methodologies especially in the synthetic biology is expected to increase the quality and the quantity of recombinant proteins with an economical value.

    Citation: Ozgun Firat Duzenli, Sezer Okay. Promoter engineering for the recombinant protein production in prokaryotic systems[J]. AIMS Bioengineering, 2020, 7(2): 62-81. doi: 10.3934/bioeng.2020007

    Related Papers:

    [1] Pawel Jajesniak, Tuck Seng Wong . From genetic circuits to industrial-scale biomanufacturing: bacterial promoters as a cornerstone of biotechnology. AIMS Bioengineering, 2015, 2(3): 277-296. doi: 10.3934/bioeng.2015.3.277
    [2] Michiro Muraki . Development of expression systems for the production of recombinant human Fas ligand extracellular domain derivatives using Pichia pastoris and preparation of the conjugates by site-specific chemical modifications: A review. AIMS Bioengineering, 2018, 5(1): 39-62. doi: 10.3934/bioeng.2018.1.39
    [3] Edwige Arnold, Iness Hammami, Jingkui Chen, Sachin Gupte, Yves Durocher, Mario Jolicoeur . Overexpression of G6PDH does not affect the behavior of HEK-293 clones stably expressing interferon-α2b. AIMS Bioengineering, 2016, 3(3): 319-336. doi: 10.3934/bioeng.2016.3.319
    [4] Liwei Chen, Jaslyn Lee, Wei Ning Chen . The use of metabolic engineering to produce fatty acid-derived biofuel and chemicals in Saccharomyces cerevisiae: a review. AIMS Bioengineering, 2016, 3(4): 468-492. doi: 10.3934/bioeng.2016.4.468
    [5] Sezer Okay, Mehmet Sezgin . Transgenic plants for the production of immunogenic proteins. AIMS Bioengineering, 2018, 5(3): 151-161. doi: 10.3934/bioeng.2018.3.151
    [6] Murtaza Shabbir Hussain, Gabriel M Rodriguez, Difeng Gao, Michael Spagnuolo, Lauren Gambill, Mark Blenner . Recent advances in bioengineering of the oleaginous yeast Yarrowia lipolytica. AIMS Bioengineering, 2016, 3(4): 493-514. doi: 10.3934/bioeng.2016.4.493
    [7] Khalil Essani, Anton Glieder, Martina Geier . Combinatorial pathway assembly in yeast. AIMS Bioengineering, 2015, 2(4): 423-436. doi: 10.3934/bioeng.2015.4.423
    [8] Mark Warburton, Hossam Omar Ali, Wai Choon Liong, Arona Martin Othusitse, Amir Zaki Abdullah Zubir, Steve Maddock, Tuck Seng Wong . OneClick: A Program for Designing Focused Mutagenesis Experiments. AIMS Bioengineering, 2015, 2(3): 126-143. doi: 10.3934/bioeng.2015.3.126
    [9] Mark Weingarten, Nathan Akhavan, Joshua Hanau, Yakov Peter . A Place to Call Home: Bioengineering Pluripotential Stem Cell Cultures. AIMS Bioengineering, 2015, 2(2): 15-28. doi: 10.3934/bioeng.2015.2.15
    [10] Jianhao Jiang, Muhammet Ceylan, Yi Zheng, Li Yao, Ramazan Asmatulu, Shang-You Yang . Poly-ε-caprolactone electrospun nanofiber mesh as a gene delivery tool. AIMS Bioengineering, 2016, 3(4): 528-537. doi: 10.3934/bioeng.2016.4.528
  • Recombinant proteins have an economical value with their utilization in many areas from food industry to pharmaceutical and chemical industry. Therefore, it is of great importance to establish optimum production systems for the proteins of interest. One of the critical steps in protein production is regulation of the gene expression. Promoters are among the key regulatory elements which can directly control the level of recombinant gene expression in a host cell. Thus, a suitable promoter is required for optimum gene expression. Promoter engineering is an innovative approach to find out the best promoter system for the expression of recombinant genes, which influences the overproduction of proteins of interest. In this review, some of the bacterial hosts highly used in recombinant protein production were discussed. Next, the importance of promoters in recombinant gene expression, and promoter engineering for enhanced protein production were described. Utilization of double promoter systems was highlighted as one of the successful techniques in overproduction of recombinant proteins. Increment in the variety and availability of the novel methodologies especially in the synthetic biology is expected to increase the quality and the quantity of recombinant proteins with an economical value.


    Recombinant proteins have been produced for over 30 years in different quantities from gram to kilogram, and prices are from tens to billions of dollars. Usage ranges from food industry to pharmaceutical and chemical industry, as well as for research purposes [1]. Recombinant proteins have great market value rising day by day, irrespective of their intended use. Therefore, it is critical to establish a production system for the proteins of interest as possible as in a high-yield and cost-effective manner. However, many parameters affect yields and costs of the proteins to be produced. In order to achieve an optimal production system, the following issues should be considered: (i) selection of host organism used as synthesis machinery for the protein of interest, (ii) characteristics of genetic elements, such as promoters or terminators, and expression plasmid chosen for heterologous production of the protein of interest, (iii) providing an appropriate growth and production medium for the host cell, (iv) ensuring the protein of interest-host cell compatibility, (v) establishing an effective downstream purification strategy. The desired success underlies the proper combination of these factors [2]. Strategies such as making modifications on expression conditions, expression vectors [3] or development of novel stable plasmid systems [4] can lead to applicable and cost-effective platforms for the production of high yields of recombinant proteins.

    To date, various eukaryotic and prokaryotic production hosts were used for recombinant protein production in small or large scale, for commercial or research purposes, for industrial or therapeutic reasons. Novel strategies such as utilization of different expression hosts, either eukaryotic or prokaryotic, development of novel recombinant strains, optimization of culture conditions, and modification of expression plasmid elements are used for optimal production of recombinant proteins. In this review, prokaryotic hosts used highly for the recombinant protein production are mentioned briefly. Then, the importance of promoters, special elements of an expression plasmid and their effect on the production of recombinant proteins in prokaryotic systems are described. Lastly, the strategies based on coupling of promoters for enhancing production efficiency of prokaryotic hosts are discussed.

    Although various hosts are used for the production of recombinant proteins, some of the bacterial species are used more commonly. Each bacterial species has its own advantages and disadvantages (Table 1). Therefore, selection of the bacterial host mainly depends on the purpose and the methodology to be used.

    Table 1.  Advantages and disadvantages of common prokaryotic host cells used for the production of recombinant proteins.
    Host Advantages Disadvantages
    Streptomyces spp.
    • Simplification of downstream process due to efficient secretion system
    • Effective secretion profile for prokaryotic-based proteins
    • Relatively low level of endogenous extracellular proteolytic activity depending on strain
    • Low production levels
    • Large-scale fermentation problems due to mycelial lifestyle
    • Hampered production of eukaryotic-based protein
    Bacillus spp.
    • Easy and inexpensive cultivation at high cell densities
    • Generally Recognized as Safe (GRAS) organism
    • High secretory capacity
    • Easy adaptation to growth media
    • Lack of suitable expression vectors
    • Plasmid instability
    • Presence of proteases
    • Occurrence of malfolded proteins
    Lactococcus lactis
    • Beneficial structures of lactic acid bacteria to human health
    • Applicability as oral vectors for protein delivery
    • GRAS organism
    • Low expression levels
    • Similar bottlenecks in protein production and secretion as Bacillus spp.
    Escherichia coli
    • Fast proliferation and high expression levels
    • Easy, quick and cheap processing and scale-up
    • Broad knowledge about physicochemical properties and genome
    • Presence of numerous genetically manipulated strains for recombinant protein production
    • Inefficient export of heterelogous proteins because of outer membrane
    • Inclusion body formation
    • Presence of endotoxins
    Corynebacterium glutamicum
    • GRAS organism
    • Lack of endotoxins
    • Ability to secrete heterologous proteins as properly folded and functional
    • Low extracellular hydrolytic enzyme activity
    • In some cases, lower growth rates and transformation efficiency
    • Fewer available expression systems,
    • Lower yields of recombinant proteins
    • Relatively expensive culture costs

     | Show Table
    DownLoad: CSV

    Streptomycetes are gram-positive bacteria and mostly live in soils containing plant and animal residues in abundance. Streptomycetes secrete large number of secondary metabolites including proteins which are economically valuable and have wide range of applications in pharmacy, food and textile industries. Many of these secondary metabolites are known as antibiotics. For example, Streptomyces aureofaciensis produces tetracycline [5], S. clavuligerus produces cephalosporin [6], S. fradiae produces neomycin [7], S. griseus produces streptomycin [8] and S. venezuelae produces chloramphenicol [9]. Secondary metabolites from Streptomyces spp. and their antibiotic effects are beyond the scope of this review and well-reviewed by the others [10][12]. Among the other Streptomyces spp., S. lividans is predominantly chosen as host for recombinant production of wide variety of proteins. In a scale-up study, it was shown that S. lividans is convenient for recombinant production of Mycobacterium tuberculosis antigen, APA [13]. Elucidating the complex metabolic mechanisms affecting protein synthesis in S. lividans improved the recombinant protein production in this industrially important species [14]. Efficient extracellular secretion mechanism of S. lividans renders this bacterium as a prominent synthesis machinery [15] for the production of wide range of heterologous proteins [16] and omics-based researches have been conducted to improve the productivity of this organism [17].

    The other production hosts for recombinant proteins are Bacillus species because of their attractive secretion system exporting the proteins into the extracellular environment [18]. This secretion system has been utilized in many studies for recombinant protein production in different Bacillus species such as B. subtilis [19][21], B. brevis [22],[23] and B. megaterium [21],[24]. Bacillus species are good choice to produce proteins especially for industrial or pharmaceutical purposes. Some appropriates such as capability of extracellular protein production, availability to high-cell density fermentation, and easy adaptivity to genetic modifications render different species of Bacillus as efficient expression systems for industrial enzyme production [25],[26]. Many of Bacillus species are known as the main sources of proteases which can be used in different fields such as food, beverage, leather, textile, detergent or pharmaceutical industries [27]. Innovative strategies are carried out to develop different Bacillus expression systems which produce high yield of recombinant proteins with expanded application fields. The attempts for optimization of secretion pathways, enhancement of RNA and protein stability, facilitating cell growth conditions, to streamlining bacterial genome and engineering transcription regulation mechanism were reported [28].

    Lactococcus lactis is known as a convenient choice for fermentation, and generally recognized as safe (GRAS) by the Food and Drug Administration (FDA) [29]. L. lactis serves as an attractive platform for recombinant protein production both for food-grade [30] and pharmaceutical [31] proteins. Besides use as a recombinant production platform for vaccine antigens [32], there are interesting efforts on using the recombinant form of L. lactis as oral or mucosal vaccine delivery system [33][37].

    Strains of Escherichia coli are used most widely for recombinant protein production over years. Some properties of E. coli such as its (i) well characterised genetic structure, (ii) suitabilitiy for genome engineering to gain different functions, (iii) cost-effectiveness, (iv) adaptivity to high level protein production protocols make this bacterium as one of the favorite synthesis machinery for the production of recombinant proteins that do not need complex post-translational modifications for functional activity [38]. E. coli is the most popular among other bacterial host for the production of pharmaceutical proteins and it was the host for somatostatin as the first recombinant protein [39]. As a recombinant protein production host, E. coli includes a great number of recombinant strains having different pros and cons relative to each other [40]. Therefore, it is crucial to choose the right E. coli strain for high yield protein production, as well as optimization of other incubation conditions. There are numerous protein products produced in different E.coli strains for medical and non-medical applications [41][44].

    Due to the rapid growth rate and appropriate secretion system, Pseudomonas species, especially P. fluorescens, might be shown as alternative expression hosts among the other recombinant protein production systems. Jin et al. [45] showed the capability of P. fluorescens for recombinant production of human granulocyte colony stimulating factor, a cytokine controlling the production, differentiation and function of granulocytes, in its active and soluble form. In addition, identified signal sequences of Pseudomonas species that facilitate the transport of expressed recombinant proteins to the periplasmic space are of interest to improve protein stability, solubility, folding and purification processes [46]. Besides, P. aeruginosa and P. putida serve as potential and efficient platforms for the recombinant production of several proteins for industrial and medical applications, as well [47].

    Corynebacterium glutamicum is another bacterial host for recombinant protein production. This bacterium has been generally used for production of amino acids like L-glutamic acid and L-lysine, for long years [48],[49]. In addition to adaptation capacity to culture medium and low protease activity, its effective secretion pathways make this species as an alternative choice for heterologous protein production [50]. Moreover, C. glutamicum was shown as a potential production host for pharmaceutical proteins at large-scale [51]. There are various studies reporting the importance of C. glutamicum for production of enzymes, antibody fragments, or saccharides [52]. Also, other studies have reported on the development of this bacterium or its growth conditions for industrial uses [53],[54].

    A promoter is an element responsible for initiation and regulation of transcription of the gene cloned into an expression plasmid [55], and also coordination of biosynthetic pathways controlled by multi-genes [56]. In a plasmid vector, this DNA region is located on the upstream of gene encoding the protein of interest. A promoter contains nucleotide sequences recognized by transcription factors and RNA polymerase (Figure 1). Concerning the expression of recombinant genes cloned on its downstream region, it is crucial to choose a compatible promoter with endogenous RNA polymerase of host cell system. Therefore, suitable promoters should be selected for prokaryotic or eukaryotic host cell systems.

    Figure 1.  Schematic representation of the conserved -35 and -10 boxes as well as the binding sites for σ factor and RNA polymerase in a prokaryotic promoter region.

    Promoters can be at the “on” formation without existence of a stimulant for activation. However, regulated promoters need a specific tissue, time, physical or chemical stimulants to switch from “on” to “off” formations or vice versa (Figure 2). Although the complex control mechanism of the cell on promoters, unwanted transcription, regarded as “leaky”, occurs in some situations. This phenomenon may lead to loss of viability of cells, production yield and stability of protein to be produced, when cloned gene or its products are toxic to expression host. To overcome leaky transcription, many of synthetic promoters regulated tightly were obtained [55],[57]. These types of prokaryotic promoters are chosen to increase stability and production yield of proteins for recombinant production. Strong promoters are generally used in recombinant protein production owing to the vital role of promoter strength on productivity. In general, strong promoters require an inducer for binding of RNA polymerase for transcription initiation. Therefore, it is desirable to achieve an efficient expression system harboring a strong promoter, non-leaky expression and requires cheap and non-lethal inducers for overproduction of recombinant proteins. For these reasons different studies for development of novel inducers [58],[59] or auto-inducible promoters [59],[60] which are useful for industrial protein production hosts have been reported. Some of the promoters for prokaryotic expression systems are listed in Table 2.

    Figure 2.  Positive and negative induction mechanisms for regulation of inducible promoters. In positive induction mechanism, (a) the promoter is inactive due to the absence of activator-promoter binding (OFF state). Upon the stimulation by inducer, the activator binds to specific DNA sites and initiates transcription (ON state). In negative induction mechanism, (b) a repressor is bound to specific DNA site and transcription is blocked (OFF state). After the stimulation via an inducer, repressor is released and the transcription is initiated (ON state).

    A promoter sequence behaves as a functional program including some of major steps: (i) recognition by RNA polymerase; (ii) isomerization of the initial complex; (iii) transcription initiation; (iv) transition to elongation complex and clearance of the promoter [61]. Commonly used promoters can be classified in three different groups (i) constitutive promoters, (ii) inducible promoters, and (iii) stationary phase promoters. The constitutive promoters may be described as promoters that are active under in vivo conditions [62]. Transcription of the gene cloned under some types of constitutive promoters, such as T3, T7 and SP6 promoters, requires RNA polymerase enzymes recognizing specific sequences on their cognate promoters for transcription [63]. Inducible promoters may be divided into two subclasses known as inducer-dependent promoters and auto-inducible promoters, based on their requirement to inducer for subsequent gene expression. The spac and xyl promoters are examples of inducible promoters induced by isopropyl β-D-1-thiogalactopyranoside (IPTG) and xylose, respectively [64]. Although inducible promoters show effective overexpression of the gene of interest, they are not widely accepted in practice for industrial protein production because of the cost of the inducer and associated host-toxic properties. Whereas expression vectors with auto-inducible promoters, that do not require an inducer in culture medium for transcription initiation, may be referred as suitable for industrial-scale protein production [65]. Some of the proteins synthesized in the stationary phase of bacterial growth are vital due to contribution to cell viability. The promoters responsible for expression of these proteins are called stationary-phase promoters. These promoters show their activity at the stage of stationary phase and less or no activity in growth phase, namely exponential (log) phase [66], and they are suitable for large-scale protein production due to both the cost-effectiveness from no requirement of an expensive inducer and absence of the possible toxic effects of inducers. Hence, attempts on identification and characterization of stationary-phase promoters are effective for enrichment of gene expression under these promoters [67],[68]. Comparative studies on promoters reveal the influence of promoter strength and activity on protein production [69],[70]. Since the strength of a promoter can be determined as measure of transcription initiation frequency, the affinity of RNA polymerase to promoter sequence may be accepted as the main effective parameter [71]. Based on this frequency, promoters are considered as weak or strong. A weak promoter generally gives low transcription, but a strong promoter produces more. However, strong promoters are not always good choices when the level of basal transcription of the gene encoding a protein of interest is deleterious or toxic for host cells [72]. Besides total amount of produced recombinant protein, the amount of protein produced in soluble form is also important. For this reason a weak promoter can enhance the solubility, while a strong promoter can enhance the amount of total protein [73].

    Table 2.  Examples of promoters used in prokaryotic organisms.
    Promoter Strain Intended use Reference
    T7 E. coli Rosetta-gami B (DE3) Recombinant production of potassium channel blocker protein [74]
    E. coli BL21 (DE3) CodonPlus Recombinant production of Pseudomonas aeruginosa exotoxin A [75]
    T7lac E. coli BLR (DE3) Expression of recombinant asparaginase fused to pelB leader sequence [76]
    E. coli BL21(DE3) pLysS and Rosetta 2(DE3) pLysS Engineering of E. coli producing 1,3-propanediol from glycerol [77]
    rpoS E. coli DH5α Engineering of E. coli strain to produce 1,3-propanediol directly from glucose [78]
    PrhaBAD E. coli To improve the production of membrane and secretory proteins in E. coli [79]
    mmsA Pseudomonas denitrificans, E. coli and P. putida To develop a biosensor for 3-hydroxypropionic acid [80]
    trc Corynebacterium glutamicum To evaluate the effect of polyhydroxybutyrate synthesis genes on L-glutamate production in Corynebacterium glutamicum [81]
    tetA E. coli K-12 and B strains Production of murine immunoglobulin Fab fragments [82]
    tac Corynebacterium glutamicum Heterologous production of amylase [83]
    lac Escherichia coli RB791 Optimizing the expression of a monoclonal antibody fragment [84]
    tacM Corynebacterium glutamicum Sec pathway-dependent production of α-amylase [85]
    PL E. coli BL21 Investigating metabolic and transcriptional responses to temperature during synthesis of pre-proinsulin [86]
    araBAD E. coli DH10B Production of TrfA replication protein [87]
    cspA E. coli BL21 To elucidate the functional alteration of the recombinant hybrid chitinases composed of bacterial and insect's domains [88]
    cspB Corynebacterium glutamicum YDK010 Production of human epidermal growth factor [51]
    phyL Bacillus licheniformis α-amylase and xylanase production as reporter proteins in development of an auto-inducible promoter [59]
    NBP3510 Bacillus subtilis Production of intracellular (BgaB, sfGFP) and extracellular (MPH, Chd) proteins [68]
    P43 Bacillus subtillis WB800N Trehalose synthetase expression for trehalose production [89]
    Pspac Bacillus subtillis β-galactosidase production [90]
    P170 Lactococcus lactis Production of nuclease from Staphylococcus aureus [91]
    Pgrac Bacillus subtilis Recombinant human bone morphogenetic protein 2 (rhBMP2) [92]
    trp E.coli K-12 Expression of different foreign genes [93]

     | Show Table
    DownLoad: CSV

    Many innovative approaches stand out for discovery or modification of prokaryotic [94] and eukaryotic [95] promoters. Obviously the identification of bacterial promoters is important to achieve higher yields of recombinant proteins produced in bacterial cell factories. Promoter engineering is a strategy to create large number of promoter libraries and to regulate promoters with different strength and functions. Many studies based on mathematical prediction, randomization of promoter sequences and hybridization of promoters are used for promoter modifications [56]. Although this strategy is one of the main topics of metabolic engineering and synthetic biology, it is also practical for overexpression of recombinant proteins. In this regard, bioinformatics serves as a useful tool for discovery of bacterial promoters [96]. Researches on identification and development of novel promoters mainly consist of three strategy: (i) discovery of novel promoters by microbial genome screening [97],[98], (ii) constructing of broad libraries of artificial promoters [94],[99] and (iii) editing the core region of existing promoters [100].

    Sequencing the genomes of different bacteria is an applicable way leading to discovery of novel promoters [101]. For this purpose, transcriptome mining may be a convenient choice as a bioinformatics tool based on genome screening, for identification of novel and stronger promoter(s) from the transcriptome data of the strain of interest. By this approach, Meng et al. [102] reported B. subtilis as an appropriate expression host for the production of pullulanase, a starch hydrolysis enzyme, at industrial quantity. In their study, four strong promoters were identified from B. subtilis transcriptome. New recombinant strains with individual promoters or combinations thereof were generated. Results from the studies on screening of endogenous promoters lead to efficient engineering of strains. Newly identified promoters can effectively optimize the molecular pathways and improve the productivity in strain of interest as well as increasing the industrial protein production [103]. High-throughput promoter screening and identification studies may be useful for developing novel expression system for research and biotechnological applications [104].

    Development of synthetic promoters has also importance for engineering of strains to produce large-scale protein production. In a study for engineering a fully synthetic promoter for constitutive protein expression, Yim et al. [105] constructed synthetic promoter libraries via green fluorescent protein as a reporter and then isolated the potential ones by fluorescence-activated cell sorting (FACS)-based high-throughput screening strategy. Different proteins were produced in large-scale to verify activity of synthetic promoters. In line with the production yields, usefulness of PH36, the strongest synthetic promoter in the study, in large-scale fed-batch production was proved. Results obtained from this study are important in the aspect of showing the effect of promoters and strength thereof for engineering a strain to extend its production capability and productivity. Zhou et al. [68] achieved overproduction of intracellular (BgaB, sfGFP) and extracellular (MPH, Chd) proteins from a single copy expression cassette in B. subtilis via modification of the core regions and upstream sequences of existing stationary phase-dependent promoter Pylb to obtain high yield transcription. Production experiments showed that the resulting promoter, NBP3510, was suitable both for overproduction of intracellular and extracellular proteins. Besides, studies relies on high-throughput screening of mutant promoters are available for optimization of promoter strength to produce the proteins in active form and with increased levels [106]. Moreover, it is possible to construct broad-spectrum promoters functional in diverse microorganisms. Since identical housekeeping sigma factors σ43 and σ70 recognize conserved -35 and -10 boxes, Yang et al. [107] designed a broad-spectrum promoter, Pbs, for E. coli, B. subtilis and Saccharomyces cerevisiae using a strong synthetic promoter platform (Pmin) for S. cerevisiae. They also used random mutagenesis to obtain three different variants, Pbs1, Pbs2 and Pbs3, differing in strength.

    Due to the vital role of promoters in gene expression, many attempts focus on discovery, development or improving the strength of promoters. In addition to other promoter-based researches, Yang et al. [108] developed phosphorothioate-based ligase-independent gene cloning method, named as PLICable-pET promoter toolbox, for evaluation of ten IPTG inducible promoters (T7, A3, lpp, tac, pac, Sp6, lac, npr, trc and syn) to determine the most suitable promoter for high yield production. By the application of PLICable-pET tool box, an increment on the production levels of different proteins was reported. They suggested this system to screen suitable promoter in a single cloning step quickly and effectively.

    In another approach, a plasmid, called as promoter trap vector, including a multiple-cloning site at the 5′ end of a marker gene without a promoter sequence can be used in promoter identification studies. In this system, it involves cloning of a couple of unknown DNA fragments and a reporter gene, and subsequent monitoring for reporter gene expression reveal novel promoters [109]. Yang et al [110] developed a promoter trap system which can shuffle and recombine different DNA fragments and screen strong promoters at the same time. In their study, partially digested genome of B. licheniformis was ligated to the promoter trap vector and then transformed into E. coli DH5α. Subsequently, recombinant strains including promoter fragments were screened. Approximately 1000 colonies potentially carrying the desired promoter were obtained using this vector system. Strength of promoters was compared based on productivity of β-galactosidase both in E. coli and B. subtilis. This study demonstrated the usefulness of promoter trap vectors for developing an artificial double promoter system consists of PluxS and a hybrid promoter from B. licheniformis. They suggested simultaneous shuffling and recombination of DNA fragments and adoption of a high throughput screening as the advantage of the trap system to create new promoters.

    One-to-one promoter comparison studies identifying suitable promoters to increase the productivity of the system may guide to generate an efficient protein production platforms [108]. In addition, this comparison studies may be helpful to show different effects of common promoters on soluble and total protein yields, in host-dependent or independent manner [73]. There are many components which should be set to obtain optimized production platform for recombinant proteins, such as modification of genetic construct [111], determination of the best host-vector combination [76], or altering the growth parameters like concentration of specific medium ingredients [112]. The combination of these parameters may be efficacious to achieve high yields of protein production. Among the choices aforementioned above, Yim et al. [111] showed the effect of genetic circuit modification to obtain desired protein levels. They examined the effects of signal sequences, codon-optimization, promoters, untranslated regions and transcriptional terminator on the yield of protein secreted into medium and significant increase was reported for secreted protein. As a result of this study, a fully synthetic promoter, H36, stands out for obtaining the highest level of protein. This promoter enhanced the production quantity 10 to 20 folds in comparison to other promoters, pSodM2 and pTrcM3, respectively. This study revealed the contribution of right promoter selection to development of efficient expression systems. A number of studies revealed the importance of correct combinations of production host, promoter and signal sequences for improvement of protein production [113]. Promoter engineering approaches are also employed for the recombinant protein production in unusual hosts. Shen et al. [114] obtained a suitable promoter for the production of poly(3-hydroxybutyrate-co-4-hydroxybutyrate) [P(3HB-co-4HB)] in Halomonas bluephagenesis. They used saturation mutagenesis approach to obtain a library for the promoter core region of porin gene (Pporin). The best promoter was used for the expression of orfZ gene in H. bluephagenesis and enhanced production of P(3HB-co-4HB) was obtained. Additionally, combinations of promoters and signal sequences might be utilized for on-line analysis of bacterial host responses during recombinant protein production [115]. Taken together, these results highlight the impact of promoter strength and combination on heterologous protein production efficiency.

    Some researchers prefer co-expression strategies to produce multi-protein complexes by more effective manner [116]. There are two commonly used method for co-expression of proteins: dual vector systems and bicistronic vector systems [117]. In dual vector system, two different genes encoding the proteins of interest are cloned into two separate expression plasmids, and these two plasmids are introduced into a single host cell. However, the problem of domination of one plasmid to the other in terms of copy number may occur when dual vector systems are used [118]. In bicistronic vector system, different genes are cloned under a single promoter. In theory, expression levels of these genes are comparable since both of them have their own ribosome binding unit but practically, the gene away from the promoter sequence is expressed less [119]. In this case, the transcription level of the second gene located away from promoter can be increased by adding a second promoter in the upstream region of this gene. Thus, the production of protein encoded by second gene can be enhanced [119],[120]. Double promoter plasmid systems have been used over years [121]. Kim et al. [120] compared the productivity of traditional bicistronic vectors and double promoter vectors, and demonstrated that the double promoter system enhanced the protein production four to nine folds. They also suggested that combination of more promoters may enhance the amount of produced protein.

    In Figure 3, a traditional bicistronic vector system and a double promoter vector system were illustrated schematically. Öztürk et al. [122] classified double promoter systems in two major groups, as consecutively (CNT)- and simultaneously (SMT)-operating ones, based on their mechanism of operation. According to this classification, SMT-operating double promoter systems can also be subdivided into three different groups as carrying two same promoters, a promoter and its variant, and two different promoters.

    Figure 3.  Schematic illustration of a traditional bicistronic vector system (a) and a double promoter vector system (b). In double promoter system P1 and P2 can be consecutively or simultaneously operating, identical or non-identical promoters. P1: promoter 1; G1: gene 1; P2: promoter 2; G2: gene 2.

    Ray et al. [123] used a dual promoter expression plasmid including two different inducible promoters and secretion genes in E.coli to take advantage of extracellular expression of the protein of interest such as achieving enhanced stability, proper folding, higher production and purification yields. Co-expression of secretion factors in dual promoter-expression plasmid maximized the extracellular production of salmon calcitonin protein. Similarly, Tao et al. [124] constructed a dual-promoter expression plasmid for recombinant production of phospholipase D (PLD) from S. halstedii in S. lividans, consisting of inducible (Ptip)/constitutive (PermE*) promoters. For this, a strong constitutive promoter, the erythromycin resistance promoter PermE*, was inserted downstream of the inducible Ptip promoter, and they could reduce both the dependence on expensive inducers and production costs.

    Liu et al. [125] combined the suitable signal peptide detection and promoter strength comparison studies to establish practical and optimal expression system for recombinant production and secretion of alkaline serine protease (BcaPRO) from B. clausii in B. subtilis WB600. Plasmids carrying signal peptide and BcaPRO gene were combined with a single promoter, as well as dual or triple promoters. Engineered expression system involving two promoters (PBsamy-PBaamy), the signal peptide (SPDac), and BcaPRO gene was found effective for high-level production of the protein of interest. In parallel, Guan et al. [126] evaluated the optimization of promoters and signal peptide combinations for secretory production of aminopeptidase (AP) in B. subtillis. After screening the library composed of approximately 20 Sec-type signal peptides, YncM was determined as the most effective one for enhancing the secretion. Later, AP and YncM were cloned to a series of expression plasmids harboring single or dual promoters. Fermentation process showed that secretory production of AP was maximized by expression vector containing YncM and AP under the PgsiB-PHpaII promoters. This study suggested that combination strategy of double promoter systems and secretory signal peptides can lead to advantageous results for recombinant secretory protein production. Moreover, Zhang et al. [127] developed a novel dual promoter expression vector for production of industrial relevant enzymes in B.subtilis. To obtain a dual promoter plasmid, a screening step was conducted with single-promoter plasmids encoding β-cyclodextrin glycosyltransferase (β-CGTase). In this step, plasmid with PamyQ promoter showed the highest activity. Next, dual-promoter vectors were constructed based on PamQ promoter and evaluated same as single-promoter vector screening study. Production studies showed that the novel constructed dual promoter plasmid, PHpaII-PamyQ, can produced β-CGTase and other industrial enzymes such as pullulanase effectively both in shake flasks and 3 L fermenters. Therefore, this dual promoter system was suggested as a potential applicable system for industrial purposes. In another study based on production of industrial enzyme, pullulanase in B. subtilis, Liu et al. [128] developed a mutant Bacillus sp. by deletion of multiple proteases. After screening and comparison studies of single- and multiple-promoters, the dual promoter system, PamyL–PspovG, was found supportive for increased extracellular protein production. Combination of host strain construction and promoter optimization, they successfully produced the enzyme pullulanase in active form and high yield. Their works demonstrated the potential applications of double-promoter plasmid systems for industrial protein production.

    Success and importance of dual promoter-based vector systems on rapid, economical and high titers production of antibodies or fragments of these complex biomolecules have shown in different types of host cells [120],[129]. Lueking et al. [130] constructed a system for inducible production of recombinant proteins both in Pichia pastoris and E. coli. In their dual promoter system they combined the eukaryotic and prokaryotic promoter elements so that E. coli T7 promoter region with the ribosome binding site was located on downstream of alcohol oxidase promoter (AOX), a strong yeast promoter. According to comparison study for human protein expression in eukaryotic and prokaryotic hosts, it was obvious that dual promoter expression system reduces workload and ensures an economic platform for production and purification of recombinant proteins both without subcloning steps. Similarly, Sinah et al. [131] suggested the dual promoter vectors as useful tools for cloning, expression, and purification of proteins both in eukaryotic and prokaryotic host or for studying post-translation modifications.

    Recombinant proteins are very valuable products for a wide range of usage areas. Due to their economical importance, conditions such as cost-effective and high-yield production of recombinant proteins in diverse hosts require optimization of many factors including gene expression. Promoters are among the key factors regulating gene expression. Therefore, utilization of an efficient promoter system is vital for recombinant protein production. The findings of many studies showed that engineering of promoters to obtain an optimal expression system as well as utilization of dual promoter-based vector systems are among the efficient strategies for enhanced production of recombinant proteins.



    Conflict of interest



    The authors declare no conflict of interest.

    [1] Puetz J, Wurm FM (2019) Recombinant proteins for industrial versus pharmaceutical purposes: a review of process and pricing. Processes 7: 476. doi: 10.3390/pr7080476
    [2] Zhang W, Yang Y, Liu X, et al. (2019) Development of a secretory expression system with high compatibility between expression elements and an optimized host for endoxylanase production in Corynebacterium glutamicumMicrob Cell Fact 18: 72. doi: 10.1186/s12934-019-1116-y
    [3] Sadeghian-Rizi T, Ebrahimi A, Moazzen F, et al. (2019) Improvement of solubility and yield of recombinant protein expression in E. coli using a two-step system. Res Pharm Sci 14: 400-407. doi: 10.4103/1735-5362.268200
    [4] Mikiewicz D, Plucienniczak A, Krzysik-Bierczynska A, et al. (2019) Novel expression vectors based on the pIGDM1 plasmid. Mol Biotechnol 61: 763-773. doi: 10.1007/s12033-019-00201-6
    [5] Duggar BM (1948) Aureomycin: a product of the continuing search for new antibiotics. Ann NY Acad Sci 51: 177-181. doi: 10.1111/j.1749-6632.1948.tb27262.x
    [6] Nagarajan R, Boeck LD, Gorman M, et al. (1971) Beta-lactam antibiotics from StreptomycesJ Am Chem Soc 93: 2308-2310. doi: 10.1021/ja00738a035
    [7] Waksman SA, Lechevalier HA (1949) Neomycin, a new antibiotic active against streptomycin-resistant bacteria, including tuberculosis organisms. Science 109: 305-307. doi: 10.1126/science.109.2830.305
    [8] Waksman SA (1953) Streptomycin: background, isolation, properties, and utilization. Science 118: 259-266. doi: 10.1126/science.118.3062.259
    [9] Vining LC, Shapiro S (1984) Chloramphenicol production in carbon-limited media: effect of methyl α-glucoside. J Antibiot 37: 74-76. doi: 10.7164/antibiotics.37.74
    [10] De Lima Procópio RE, Da Silva IR, Martins MK, et al. (2012) Antibiotics produced by StreptomycesBraz J Infect Dis 16: 466-471. doi: 10.1016/j.bjid.2012.08.014
    [11] Baltz RH (2010) Streptomyces and Saccharopolyspora hosts for heterologous expression of secondary metabolite gene clusters. J Ind Microbiol Biotechnol 37: 759-772. doi: 10.1007/s10295-010-0730-9
    [12] Raja A, Prabakarana P (2011) Actinomycetes and drug-an overview. Am J Drug Discov Dev 1: 75-84. doi: 10.3923/ajdd.2011.75.84
    [13] Gamboa-Suasnavart RA, Marín-Palacio LD, Martínez-Sotelo JA, et al. (2013) Scale-up from shake flasks to bioreactor, based on power input and Streptomyces lividans morphology, for the production of recombinant APA (45/47 kDa protein) from Mycobacterium tuberculosisWorld J Microbiol Biotechnol 29: 1421-1429. doi: 10.1007/s11274-013-1305-5
    [14] Muhamadali H, Xu Y, Ellis DI, et al. (2015) Metabolomics investigation of recombinant mTNFα production in Streptomyces lividansMicrob Cell Fact 14: 157-157. doi: 10.1186/s12934-015-0350-1
    [15] Hamed MB, Karamanou S, Olafsdottir S, et al. (2017) Large-scale production of a thermostable Rhodothermus marinus cellulase by heterologous secretion from Streptomyces lividans. Microb Cell Fact 16: 232. doi: 10.1186/s12934-017-0847-x
    [16] Anné J, Maldonado B, Van Impe J, et al. (2012) Recombinant protein production and StreptomycetesJ Biotechnol 158: 159-167. doi: 10.1016/j.jbiotec.2011.06.028
    [17] Daniels W, Bouvin J, Busche T, et al. (2018) Transcriptomic and fluxomic changes in Streptomyces lividans producing heterologous protein. Microb Cell Fact 17: 198. doi: 10.1186/s12934-018-1040-6
    [18] Simonen M, Palva I (1993) Protein secretion in Bacillus speciesMicrobiol Mol Biol Rev 57: 109-137.
    [19] Wu SC, Ye R, Wu XC, et al. (1998) Enhanced secretory production of a single-chain antibody fragment from Bacillus subtilis by coproduction of molecular chaperones. J Bacteriol 180: 2830-2835. doi: 10.1128/JB.180.11.2830-2835.1998
    [20] Wu SC, Yeung JC, Duan Y, et al. (2002) Functional production and characterization of a fibrin-specific single-chain antibody fragment from Bacillus subtilis: effects of molecular chaperones and a wall-bound protease on antibody fragment production. Appl Environ Microbiol 68: 3261-3269. doi: 10.1128/AEM.68.7.3261-3269.2002
    [21] Lakowitz A, Krull R, Biedendieck R (2017) Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains. Microb Cell Fact 16: 14. doi: 10.1186/s12934-017-0625-9
    [22] Inoue Y, Ohta T, Tada H, et al. (1997) Efficient production of a functional mouse/human chimeric Fab′ against human urokinase-type plasminogen activator by Bacillus brevisAppl Microbiol Biotechnol 48: 487-492. doi: 10.1007/s002530051084
    [23] Shiroza T, Shinozaki-Kuwahara N, Hayakawa M, et al. (2003) Production of a single-chain variable fraction capable of inhibiting the Streptococcus mutans glucosyltransferase in Bacillus brevis: construction of a chimeric shuttle plasmid secreting its gene product. Biochim Biophys Acta 1626: 57-64. doi: 10.1016/S0167-4781(03)00038-1
    [24] Jordan E, Hust M, Roth A, et al. (2007) Production of recombinant antibody fragments in Bacillus megateriumMicrob Cell Fact 6: 2. doi: 10.1186/1475-2859-6-2
    [25] Wang H, Zhang X, Qiu J, et al. (2019) Development of Bacillus amyloliquefaciens as a high-level recombinant protein expression system. J Ind Microbiol Biotechnol 46: 113-123. doi: 10.1007/s10295-018-2089-2
    [26] Zhang XZ, Cui ZL, Hong Q, et al. (2005) High-level expression and secretion of methyl parathion hydrolase in Bacillus subtilis WB800. Appl Environ Microbiol 71: 4101-4103. doi: 10.1128/AEM.71.7.4101-4103.2005
    [27] Contesini FJ, De Melo RR, Sato HH (2018) An overview of Bacillus proteases: from production to application. Crit Rev Biotechnol 38: 321-334. doi: 10.1080/07388551.2017.1354354
    [28] Cai D, Rao Y, Zhan Y, et al. (2019) Engineering Bacillus for efficient production of heterologous protein: current progress, challenge and prospect. J Appl Microbiol 126: 1632-1642. doi: 10.1111/jam.14192
    [29] Song AAL, In LLA, Lim SHE, et al. (2017) A review on Lactococcus lactis: from food to factory. Microb Cell Fact 16: 55. doi: 10.1186/s12934-017-0669-x
    [30] Boumaiza M, Colarusso A, Parrilli E, et al. (2018) Getting value from the waste: recombinant production of a sweet protein by Lactococcus lactis grown on cheese whey. Microb Cell Fact 17: 126. doi: 10.1186/s12934-018-0974-z
    [31] Singh SK, Tiendrebeogo RW, Chourasia BK, et al. (2018) Lactococcus lactis provides an efficient platform for production of disulfide-rich recombinant proteins from Plasmodium falciparumMicrob Cell Fact 17: 55. doi: 10.1186/s12934-018-0902-2
    [32] Rezaei M, Rabbani Khorasgani M, Zarkesh Esfahani SH, et al. (2019) Production of Brucella melitensis Omp16 protein fused to the human interleukin 2 in Lactococcus lactis MG1363 toward developing a Lactococcus-based vaccine against brucellosis. Can J Microbiol 66: 39-45. doi: 10.1139/cjm-2019-0261
    [33] Lahiri A, Sharif S, Mallick AI (2019) Intragastric delivery of recombinant Lactococcus lactis displaying ectodomain of influenza matrix protein 2 (M2e) and neuraminidase (NA) induced focused mucosal and systemic immune responses in chickens. Mol Immunol 114: 497-512. doi: 10.1016/j.molimm.2019.08.015
    [34] Song S, Li P, Zhang R, et al. (2019) Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses. Vaccine 37: 4364-4369. doi: 10.1016/j.vaccine.2019.06.026
    [35] Ghasemi Z, Varasteh AR, Moghadam M, et al. (2018) Production of recombinant protein of Salsola kali (Sal k1) pollen allergen in Lactococcus lactisIran J Allergy Asthma Immunol 17: 134-143.
    [36] Taghinezhad-S S, Mohseni AH, Keyvani H, et al. (2019) Protection against human papillomavirus type 16-induced tumors in C57BL/6 mice by mucosal vaccination with Lactococcus lactis NZ9000 expressing E6 oncoprotein. Microb Pathog 126: 149-156. doi: 10.1016/j.micpath.2018.10.043
    [37] Loh JMS, Lorenz N, Tsai CJY, et al. (2017) Mucosal vaccination with pili from Group A Streptococcus expressed on Lactococcus lactis generates protective immune responses. Sci Rep 7: 7174. doi: 10.1038/s41598-017-07602-0
    [38] Joseph BC, Pichaimuthu S, Srimeenakshi S, et al. (2015) An overview of the parameters for recombinant protein expression in Escherichia coliJ Cell Sci Ther 6: 1000221. doi: 10.4172/2157-7013.1000221
    [39] Itakura K, Hirose T, Crea R, et al. (1977) Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science 198: 1056-1063. doi: 10.1126/science.412251
    [40] Hayat SMG, Farahani N, Golichenati B, et al. (2018) Recombinant protein expression in Escherichia coli (E.coli): what we need to know. Curr Pharm Des 24: 718-725. doi: 10.2174/1381612824666180131121940
    [41] Tripathi NK (2016) Production and purification of recombinant proteins from Escherichia coliChem Bio Eng Rev 3: 116-133.
    [42] Liu HL, Yang SJ, Liu Q, et al. (2018) A process for production of trehalose by recombinant trehalose synthase and its purification. Enzyme Microb Technol 113: 83-90. doi: 10.1016/j.enzmictec.2017.11.008
    [43] Celesia D, Salzmann I, Porto EV, et al. (2017) Production of a recombinant catechol 2,3-dioxygenase for the degradation of micropollutants. CHIMIA Int J Chem 71: 734-738. doi: 10.2533/chimia.2017.734
    [44] Tajbakhsh M, Akhavan MM, Fallah F, et al. (2018) A recombinant snake cathelicidin derivative peptide: antibiofilm properties and expression in Escherichia coliBiomolecules 8: 118. doi: 10.3390/biom8040118
    [45] Jin H, Cantin GT, Maki S, et al. (2011) Soluble periplasmic production of human granulocyte colony-stimulating factor (G-CSF) in Pseudomonas fluorescensProtein Expres Purif 78: 69-77. doi: 10.1016/j.pep.2011.03.002
    [46] Retallack DM, Schneider JC, Mitchell J, et al. (2007) Transport of heterologous proteins to the periplasmic space of Pseudomonas fluorescens using a variety of native signal sequences. Biotechnol Lett 29: 1483-1491. doi: 10.1007/s10529-007-9415-5
    [47] Chen R (2012) Bacterial expression systems for recombinant protein production: E. coli and beyond. Biotechnol Adv 30: 1102-1107. doi: 10.1016/j.biotechadv.2011.09.013
    [48] Hermann T (2003) Industrial production of amino acids by coryneform bacteria. J Biotechnol 104: 155-172. doi: 10.1016/S0168-1656(03)00149-4
    [49] Kondoh M, Hirasawa T (2019) L-cysteine production by metabolically engineered Corynebacterium glutamicumAppl Microbiol Biotechnol 103: 2609-2619. doi: 10.1007/s00253-019-09663-9
    [50] Liu X, Zhang W, Zhao Z, et al. (2017) Protein secretion in Corynebacterium glutamicumCrit Rev Biotechnol 37: 541-551. doi: 10.1080/07388551.2016.1206059
    [51] Date M, Itaya H, Matsui H, et al. (2006) Secretion of human epidermal growth factor by Corynebacterium glutamicumLett Appl Microbiol 42: 66-70. doi: 10.1111/j.1472-765X.2005.01802.x
    [52] Lee MJ, Kim P (2018) Recombinant protein expression system in Corynebacterium glutamicum and its application. Front Microbiol 9: 2523. doi: 10.3389/fmicb.2018.02523
    [53] Haas T, Graf M, Nieß A, et al. (2019) Identifying the growth modulon of Corynebacterium glutamicumFront Microbiol 10: 974. doi: 10.3389/fmicb.2019.00974
    [54] Felpeto-Santero C, Galan B, Luengo JM, et al. (2019) Identification and expression of the 11β-steroid hydroxylase from Cochliobolus lunatus in Corynebacterium glutamicumMicrob Biotechnol 12: 856-868. doi: 10.1111/1751-7915.13428
    [55] Overton TW (2014) Recombinant protein production in bacterial hosts. Drug Discov Today 19: 590-601. doi: 10.1016/j.drudis.2013.11.008
    [56] Jin LQ, Jin WR, Ma ZC, et al. (2019) Promoter engineering strategies for the overproduction of valuable metabolites in microbes. Appl Microbiol Biotechnol 103: 8725-8736. doi: 10.1007/s00253-019-10172-y
    [57] Goldstein MA, Doi RH (1995) Prokaryotic promoters in biotechnology. Biotechnology Annual Review Amsterdam: Elsevier, 105-128. doi: 10.1016/S1387-2656(08)70049-8
    [58] Chaudhary AK, Lee EY (2015) Tightly regulated and high level expression vector construction for Escherichia coli BL21 (DE3). J Ind Eng Chem 31: 367-373. doi: 10.1016/j.jiec.2015.07.011
    [59] Trung NT, Hung NM, Thuan NH, et al. (2019) An auto-inducible phosphate-controlled expression system of Bacillus licheniformisBMC Biotechnol 19: 3. doi: 10.1186/s12896-018-0490-6
    [60] Meyers A, Furtmann C, Gesing K, et al. (2019) Cell density—dependent auto—inducible promoters for expression of recombinant proteins in Pseudomonas putidaMicrob Biotechnol 12: 1003-1013. doi: 10.1111/1751-7915.13455
    [61] Brunner M, Bujard H (1987) Promoter recognition and promoter strength in the Escherichia coli system. EMBO J 6: 3139-3144. doi: 10.1002/j.1460-2075.1987.tb02624.x
    [62] Shimada T, Yamazaki Y, Tanaka K, et al. (2014) The whole set of constitutive promoters recognized by RNA polymerase RpoD holoenzyme of Escherichia coliPLoS One 9: e90447. doi: 10.1371/journal.pone.0090447
    [63] Pavco PA, Steege DA (1991) Characterization of elongating T7 and SP6 RNA polymerases and their response to a roadblock generated by a site-specific DNA binding protein. Nucleic Acids Res 19: 4639-4646. doi: 10.1093/nar/19.17.4639
    [64] Vavrová Ľ, Muchová K, Barák I (2010) Comparison of different Bacillus subtilis expression systems. Res Microbiol 161: 791-797. doi: 10.1016/j.resmic.2010.09.004
    [65] Retnoningrum DS, Santika IWM, Kesuma S, et al. (2019) Construction and characterization of a medium copy number expression vector carrying auto-inducible dps promoter to overproduce a bacterial superoxide dismutase in Escherichia coliMol Biotechnol 61: 231-240. doi: 10.1007/s12033-018-00151-5
    [66] Jaishankar J, Srivastava P (2017) Molecular basis of stationary phase survival and applications. Front Microbiol 8: 2000. doi: 10.3389/fmicb.2017.02000
    [67] Xu J, Liu X, Yu X, et al. (2020) Identification and characterization of sequence signatures in the Bacillus subtilis promoter Pylb for tuning promoter strength. Biotechnol Lett 42: 115-124. doi: 10.1007/s10529-019-02749-4
    [68] Zhou C, Ye B, Cheng S, et al. (2019) Promoter engineering enables overproduction of foreign proteins from a single copy expression cassette in Bacillus subtilisMicrob Cell Fact 18: 111. doi: 10.1186/s12934-019-1159-0
    [69] Yu X, Xu J, Liu X, et al. (2015) Identification of a highly efficient stationary phase promoter in Bacillus subtilisSci Rep 5: 18405. doi: 10.1038/srep18405
    [70] Ma Y, Cui Y, Du L, et al. (2018) Identification and application of a growth-regulated promoter for improving L-valine production in Corynebacterium glutamicumMicrob Cell Fact 17: 185. doi: 10.1186/s12934-018-1031-7
    [71] Brewster RC, Jones DL, Phillips R (2012) Tuning promoter strength through RNA polymerase binding site design in Escherichia coliPLoS Comput Biol 8: e1002811. doi: 10.1371/journal.pcbi.1002811
    [72] Hannig G, Makrides SC (1998) Strategies for optimizing heterologous protein expression in Escherichia coliTrends Biotechnol 16: 54-60. doi: 10.1016/S0167-7799(97)01155-4
    [73] Tegel H, Ottosson J, Hober S (2011) Enhancing the protein production levels in Escherichia coli with a strong promoter. FEBS J 278: 729-739. doi: 10.1111/j.1742-4658.2010.07991.x
    [74] Seyfi R, Babaeipour V, Mofid MR, et al. (2019) Expression and production of recombinant scorpine as a potassium channel blocker protein in Escherichia coliBiotechnol Appl Bioc 66: 119-129. doi: 10.1002/bab.1704
    [75] Qaiser H, Aslam F, Iftikhar S, et al. (2018) Construction and recombinant expression of Pseudomonas aeruginosa truncated exotoxin A in Escherichia coliCell Mol Biol 64: 64-69. doi: 10.14715/cmb/2018.64.1.12
    [76] Khushoo A, Pal Y, Mukherjee KJ (2005) Optimization of extracellular production of recombinant asparaginase in Escherichia coli in shake-flask and bioreactor. Appl Microbiol Biotechnol 68: 189-197. doi: 10.1007/s00253-004-1867-0
    [77] Przystałowska H, Zeyland J, Kosmider A, et al. (2015) 1, 3-propanediol production by Escherichia coli using genes from Citrobacter freundii atcc 8090. Acta Biochim Pol 62: 589-597. doi: 10.18388/abp.2015_1061
    [78] Liang Q, Zhang H, Li S, et al. (2011) Construction of stress-induced metabolic pathway from glucose to 1,3-propanediol in Escherichia coliAppl Microbiol Biotechnol 89: 57-62. doi: 10.1007/s00253-010-2853-3
    [79] Hjelm A, Karyolaimos A, Zhang Z, et al. (2017) Tailoring Escherichia coli for the L-rhamnose Pbad promoter-based production of membrane and secretory proteins. ACS Synth Biol 6: 985-994. doi: 10.1021/acssynbio.6b00321
    [80] Nguyen NH, Kim JR, Park S (2019) Development of biosensor for 3-hydroxypropionic acid. Biotechnol Bioproc E 24: 109-118. doi: 10.1007/s12257-018-0380-8
    [81] Liu Q, Ouyanga S, Kim J, et al. (2007) The impact of PHB accumulation on L-glutamate production by recombinant Corynebacterium glutamicumJ Biotechnol 132: 273-279. doi: 10.1016/j.jbiotec.2007.03.014
    [82] Skerra A (1994) Use of the tetracycline promoter for the tightly regulated production of a murine antibody fragment in Escherichia coliGene 151: 131-135. doi: 10.1016/0378-1119(94)90643-2
    [83] Suzuki N, Watanabe K, Okibe N, et al. (2008) Identification of new secreted proteins and secretion of heterologous amylase by C. glutamicumAppl Microbiol Biotechnol 82: 491-500. doi: 10.1007/s00253-008-1786-6
    [84] Donovan RS, Robinson CW, Glick BR (2000) Optimizing the expression of a monoclonal antibody fragment under the transcriptional control of the Escherichia coli lac promoter. Can J Microbiol 46: 532-541. doi: 10.1139/w00-026
    [85] Jia H, Li H, Zhang L, et al. (2018) Development of a novel gene expression system for secretory production of heterologous proteins via the general secretory (sec) pathway in Corynebacterium glutamicumIran J Biotechnol 16: e1746.
    [86] Caspeta L, Flores N, Pérez NO, et al. (2009) The effect of heating rate on Escherichia coli metabolism, physiological stress, transcriptional response, and production of temperature-induced recombinant protein: a scale-down study. Biotechnol Bioeng 102: 468-482. doi: 10.1002/bit.22084
    [87] Wild J, Hradecna Z, Szybalski W (2002) Conditionally amplifiable BACs: switching from single-copy to high-copy vectors and genomic clones. Genome Res 12: 1434-1444. doi: 10.1101/gr.130502
    [88] Paek A, Kim MJ, Park HY, et al. (2020) Functional expression of recombinant hybrid enzymes composed of bacterial and insect's chitinase domains in E. coliEnzyme Microb Technol 136: 109492. doi: 10.1016/j.enzmictec.2019.109492
    [89] Liu H, Wang S, Song L, et al. (2019) Trehalose production using recombinant trehalose synthase in Bacillus subtilis by integrating fermentation and biocatalysis. J Agric Food Chem 67: 9314-9324. doi: 10.1021/acs.jafc.9b03402
    [90] Phan HTT, Nhi NNY, Tien LT, et al. (2019) Construction of expression plasmid for Bacillus subtilis using Pspac promoter and BgaB as a reporter. Sci Technol Dev J 22: 239-246. doi: 10.32508/stdj.v22i2.1284
    [91] Jørgensen CM, Vrang A, Madsen SM (2014) Recombinant protein expression in Lactococcus lactis using the P170 expression system. FEMS Microbiol Lett 351: 170-178. doi: 10.1111/1574-6968.12351
    [92] Hanif MU, Gul R, Hanif MI, et al. (2017) Heterologous secretory expression and characterization of dimerized bone morphogenetic protein 2 in Bacillus subtilisBiomed Res Int 2017: 9350537. doi: 10.1155/2017/9350537
    [93] Hallewell RA, Emtage S (1980) Plasmid vectors containing the tryptophan operon promoter suitable for efficient regulated expression of foreign genes. Gene 9: 27-47. doi: 10.1016/0378-1119(80)90165-1
    [94] Han L, Cui W, Suo F, et al. (2019) Development of a novel strategy for robust synthetic bacterial promoters based on a stepwise evolution targeting the spacer region of the core promoter in Bacillus subtilisMicrob Cell Fact 18: 96. doi: 10.1186/s12934-019-1148-3
    [95] Pothoulakis G, Ellis T (2018) Construction of hybrid regulated mother-specific yeast promoters for inducible differential gene expression. PLoS One 13: e0194588. doi: 10.1371/journal.pone.0194588
    [96] Zhang M, Li F, Marquez-Lago TT, et al. (2019) MULTiPly: a novel multi-layer predictor for discovering general and specific types of promoters. Bioinformatics 35: 2957-2965. doi: 10.1093/bioinformatics/btz016
    [97] Liu X, Yang H, Zheng J, et al. (2017) Identification of strong promoters based on the transcriptome of Bacillus licheniformisBiotechnol Lett 39: 873-881. doi: 10.1007/s10529-017-2304-7
    [98] Yuan F, Li K, Zhou C, et al. (2020) Identification of two novel highly inducible promoters from Bacillus licheniformis by screening transcriptomic data. Genomics 112: 1866-1871. doi: 10.1016/j.ygeno.2019.10.021
    [99] Wang Y, Wang H, Liu L, et al. (2019) Synthetic promoter design in Escherichia coli based on generative adversarial network. BioRxiv 2019: 563775.
    [100] Presnell KV, Flexer-Harrison M, Alper HS (2019) Design and synthesis of synthetic UP elements for modulation of gene expression in Escherichia coliSynth Syst Biotechnol 4: 99-106. doi: 10.1016/j.synbio.2019.04.002
    [101] Rhodius VA, Mutalik VK (2010) Predicting strength and function for promoters of the Escherichia coli alternative sigma factor, σEPNAS 107: 2854-2859. doi: 10.1073/pnas.0915066107
    [102] Meng F, Zhu X, Nie T, et al. (2018) Enhanced expression of pullulanase in Bacillus subtilis by new strong promoters mined from transcriptome data, both alone and in combination. Front Microbiol 9: 2635. doi: 10.3389/fmicb.2018.02635
    [103] Hou Y, Chen S, Wang J, et al. (2019) Isolating promoters from Corynebacterium ammoniagenes ATCC 6871 and application in CoA synthesis. BMC Biotechnol 19: 76. doi: 10.1186/s12896-019-0568-9
    [104] Wang J, Ai X, Mei H, et al. (2013) High-throughput identification of promoters and screening of highly active promoter-5′-UTR DNA region with different characteristics from Bacillus thuringiensisPLoS One 8: e62960. doi: 10.1371/journal.pone.0062960
    [105] Yim SS, An SJ, Kang M, et al. (2013) Isolation of fully synthetic promoters for high-level gene expression in Corynebacterium glutamicumBiotechnol Bioeng 110: 2959-2969. doi: 10.1002/bit.24954
    [106] Nie Z, Luo H, Li J, et al. (2020) High-throughput screening of T7 promoter mutants for soluble expression of cephalosporin C acylase in E. coliAppl Biochem Biotechnol 190: 293-304. doi: 10.1007/s12010-019-03113-y
    [107] Yang S, Liu Q, Zhang Y, et al. (2018) Construction and characterization of broad-spectrum promoters for synthetic biology. ACS Synth Biol 7: 287-291. doi: 10.1021/acssynbio.7b00258
    [108] Yang J, Ruff AJ, Hamer SN, et al. (2016) Screening through the PLICable promoter toolbox enhances protein production in Escherichia coliBiotechnol J 11: 1639-1647. doi: 10.1002/biot.201600270
    [109] Aoki S, Kondo T, Ishiura M (2002) A promoter-trap vector for clock-controlled genes in the cyanobacterium Synechocystis sp. PCC 6803. J Microbiol Methods 49: 265-274. doi: 10.1016/S0167-7012(01)00376-1
    [110] Yang M, Zhang W, Ji S, et al. (2013) Generation of an artificial double promoter for protein expression in Bacillus subtilis through a promoter trap system. PLoS one 8: e56321. doi: 10.1371/journal.pone.0056321
    [111] Yim SS, An SJ, Choi JW, et al. (2014) High-level secretory production of recombinant single-chain variable fragment (scFv) in Corynebacterium glutamicumAppl Microbiol Biotechnol 98: 273-284. doi: 10.1007/s00253-013-5315-x
    [112] Morowvat MH, Babaeipour V, Memari HR, et al. (2015) Optimization of fermentation conditions for recombinant human interferon beta production by Escherichia coli using the response surface methodology. Jundishapur J Microbiol 8: e16236. doi: 10.5812/jjm.8(4)2015.16236
    [113] Sevillano L, Vijgenboom E, van Wezel GP, et al. (2016) New approaches to achieve high level enzyme production in Streptomyces lividansMicrob Cell Fact 15: 28. doi: 10.1186/s12934-016-0425-7
    [114] Shen R, Yin J, Ye JW, et al. (2018) Promoter engineering for enhanced P (3HB-co-4HB) production by Halomonas bluephagenesisACS Synth Biol 7: 1897-1906. doi: 10.1021/acssynbio.8b00102
    [115] Gawin A, Peebo K, Hans S, et al. (2019) Construction and characterization of broad-host-range reporter plasmid suitable for on-line analysis of bacterial host responses related to recombinant protein production. Microb Cell Fact 18: 80. doi: 10.1186/s12934-019-1128-7
    [116] Thakur KG, Jaiswal RK, Shukla JK, et al. (2010) Over-expression and purification strategies for recombinant multi-protein oligomers: A case study of Mycobacterium tuberculosis σ/anti-σ factor protein complexes. Protein Express Purif 74: 223-230. doi: 10.1016/j.pep.2010.06.018
    [117] Dzivenu OK, Park HH, Wu H (2004) General co-expression vectors for the overexpression of heterodimeric protein complexes in Escherichia coliProtein Express Purif 38: 1-8. doi: 10.1016/j.pep.2004.07.016
    [118] Johnston K, Clements A, Venkataramani RN, et al. (2000) Coexpression of proteins in bacteria using T7-based expression plasmids: expression of heteromeric cell-cycle and transcriptional regulatory complexes. Protein Express Purif 20: 435-443. doi: 10.1006/prep.2000.1313
    [119] Rucker P, Torti FM, Torti SV (1997) Recombinant ferritin: modulation of subunit stoichiometry in bacterial expression systems. Protein Eng 10: 967-973. doi: 10.1093/protein/10.8.967
    [120] Kim KJ, Kim HE, Lee KH, et al. (2004) Two-promoter vector is highly efficient for overproduction of protein complexes. Protein Sci 13: 1698-1703. doi: 10.1110/ps.04644504
    [121] McNally EM, Goodwin EB, Spudich JA, et al. (1988) Coexpression and assembly of myosin heavy chain and myosin light chain in Escherichia coliProc Natl Acad Sci 85: 7270-7273. doi: 10.1073/pnas.85.19.7270
    [122] Öztürk S, Ergün BG, Çalık P (2017) Double promoter expression systems for recombinant protein production by industrial microorganisms. Appl Microbiol Biotechnol 101: 7459-7475. doi: 10.1007/s00253-017-8487-y
    [123] Ray MVL, Meenan CP, Consalvo AP, et al. (2002) Production of salmon calcitonin by direct expression of a glycine-extended precursor in Escherichia coliProtein Express Purif 26: 249-259. doi: 10.1016/S1046-5928(02)00523-5
    [124] Tao X, Zhao M, Zhang Y, et al. (2019) Comparison of the expression of phospholipase D from Streptomyces halstedii in different hosts and its over-expression in Streptomyces lividansFEMS Microbiol Lett 366: fnz051.
    [125] Liu Y, Shi C, Li D, et al. (2019) Engineering a highly efficient expression system to produce BcaPRO protease in Bacillus subtilis by an optimized promoter and signal peptide. Int J Biol Macromol 138: 903-911. doi: 10.1016/j.ijbiomac.2019.07.175
    [126] Guan C, Cui W, Cheng J, et al. (2016) Construction of a highly active secretory expression system via an engineered dual promoter and a highly efficient signal peptide in Bacillus subtilisNew Biotechnol 33: 372-379. doi: 10.1016/j.nbt.2016.01.005
    [127] Zhang K, Su L, Duan X, et al. (2017) High-level extracellular protein production in Bacillus subtilis using an optimized dual-promoter expression system. Microb Cell Fact 16: 32. doi: 10.1186/s12934-017-0649-1
    [128] Liu X, Wang H, Wang B, et al. (2018) Efficient production of extracellular pullulanase in Bacillus subtilis ATCC6051 using the host strain construction and promoter optimization expression system. Microb Cell Fact 17: 163. doi: 10.1186/s12934-018-1011-y
    [129] Bayat H, Hossienzadeh S, Pourmaleki E, et al. (2018) Evaluation of different vector design strategies for the expression of recombinant monoclonal antibody in CHO cells. Prep Biochem Biotechnol 48: 160-164. doi: 10.1080/10826068.2017.1421966
    [130] Lueking A, Holz C, Gotthold C, et al. (2000) A system for dual protein expression in Pichia pastoris and Escherichia coliProtein Express Purif 20: 372-378. doi: 10.1006/prep.2000.1317
    [131] Sinah N, Williams CA, Piper RC, et al. (2012) A set of dual promoter vectors for high throughput cloning, screening, and protein expression in eukaryotic and prokaryotic systems from a single plasmid. BMC Biotechnol 12: 54. doi: 10.1186/1472-6750-12-54
  • This article has been cited by:

    1. Ana Rotter, Michéle Barbier, Francesco Bertoni, Atle M. Bones, M. Leonor Cancela, Jens Carlsson, Maria F. Carvalho, Marta Cegłowska, Jerónimo Chirivella-Martorell, Meltem Conk Dalay, Mercedes Cueto, Thanos Dailianis, Irem Deniz, Ana R. Díaz-Marrero, Dragana Drakulovic, Arita Dubnika, Christine Edwards, Hjörleifur Einarsson, Ayşegül Erdoǧan, Orhan Tufan Eroldoǧan, David Ezra, Stefano Fazi, Richard J. FitzGerald, Laura M. Gargan, Susana P. Gaudêncio, Marija Gligora Udovič, Nadica Ivošević DeNardis, Rósa Jónsdóttir, Marija Kataržytė, Katja Klun, Jonne Kotta, Leila Ktari, Zrinka Ljubešić, Lada Lukić Bilela, Manolis Mandalakis, Alexia Massa-Gallucci, Inga Matijošytė, Hanna Mazur-Marzec, Mohamed Mehiri, Søren Laurentius Nielsen, Lucie Novoveská, Donata Overlingė, Giuseppe Perale, Praveen Ramasamy, Céline Rebours, Thorsten Reinsch, Fernando Reyes, Baruch Rinkevich, Johan Robbens, Eric Röttinger, Vita Rudovica, Jerica Sabotič, Ivo Safarik, Siret Talve, Deniz Tasdemir, Xenia Theodotou Schneider, Olivier P. Thomas, Anna Toruńska-Sitarz, Giovanna Cristina Varese, Marlen I. Vasquez, The Essentials of Marine Biotechnology, 2021, 8, 2296-7745, 10.3389/fmars.2021.629629
    2. Sara Restrepo-Pineda, Néstor O. Pérez, Norma A Valdez-Cruz, Mauricio A Trujillo-Roldán, Thermoinducible expression system for producing recombinant proteins in Escherichia coli: advances and insights, 2021, 1574-6976, 10.1093/femsre/fuab023
    3. Grace N. Ijoma, Sylvie M. Heri, Tonderayi S. Matambo, Memory Tekere, Trends and Applications of Omics Technologies to Functional Characterisation of Enzymes and Protein Metabolites Produced by Fungi, 2021, 7, 2309-608X, 700, 10.3390/jof7090700
    4. Sara P.O. Santos, Luis Fabian S. Garcés, Filipe S.R. Silva, Leonardo F. Santiago, Carina S. Pinheiro, Neuza M. Alcantara-Neves, Luis G.C. Pacheco, Engineering an optimized expression operating unit for improved recombinant protein production in Escherichia coli, 2022, 199, 10465928, 106150, 10.1016/j.pep.2022.106150
    5. Inkar Castellanos-Huerta, Gabriela Gómez-Verduzco, Guillermo Tellez-Isaias, Guadalupe Ayora-Talavera, Bernardo Bañuelos-Hernández, Víctor Manuel Petrone-García, Isidro Fernández-Siurob, Luis Alberto Garcia-Casillas, Gilberto Velázquez-Juárez, Dunaliella salina as a Potential Biofactory for Antigens and Vehicle for Mucosal Application, 2022, 10, 2227-9717, 1776, 10.3390/pr10091776
    6. Haneur Lee, Eun Seon Song, Yun Haeng Lee, Ji Yun Park, Myeong Uk Kuk, Hyung Wook Kwon, Hyungmin Roh, Joon Tae Park, A novel hybrid promoter capable of continuously producing proteins in high yield, 2023, 650, 0006291X, 103, 10.1016/j.bbrc.2023.02.017
    7. Fidan Erden-Karaoğlan, Mert Karaoğlan, Applicability of the heterologous yeast promoters for recombinant protein production in Pichia pastoris, 2022, 106, 0175-7598, 7073, 10.1007/s00253-022-12183-8
    8. Haiquan Yang, Haokun Wang, Fuxiang Wang, Kunjie Zhang, Jinfeng Qu, Jianmin Guan, Wei Shen, Yu Cao, Yuanyuan Xia, Xianzhong Chen, Efficient extracellular production of recombinant proteins in E. coli via enhancing expression of dacA on the genome, 2022, 49, 1367-5435, 10.1093/jimb/kuac016
    9. Prasanth Karaiyan, Catherine Ching Han Chang, Eng-Seng Chan, Beng Ti Tey, Ramakrishnan Nagasundara Ramanan, Chien Wei Ooi, In silico screening and heterologous expression of soluble dimethyl sulfide monooxygenases of microbial origin in Escherichia coli, 2022, 106, 0175-7598, 4523, 10.1007/s00253-022-12008-8
    10. Gboyega E. Adebami, Arindam Kuila, Obinna M. Ajunwa, Samuel A. Fasiku, Michael D. Asemoloye, Genetics and metabolic engineering of yeast strains for efficient ethanol production, 2022, 45, 0145-8876, 10.1111/jfpe.13798
    11. Hui-Seon Yun, Jong-Pyo Kim, Eun-Jung Kim, Byung-Gee Kim, Hee-Jin Jeong, A rapid ELISA for the detection of matrix metallopeptidase 9 using a recombinant Fab-type antibody, 2022, 636, 0006291X, 184, 10.1016/j.bbrc.2022.10.087
    12. Aarjoo Sharma, Sanjeev Balda, Neena Capalash, Prince Sharma, Engineering multifunctional enzymes for agro-biomass utilization, 2022, 347, 09608524, 126706, 10.1016/j.biortech.2022.126706
    13. Larissa Balabanova, Aleksandra Seitkalieva, Yulia Yugay, Tatiana Rusapetova, Lubov Slepchenko, Anna Podvolotskaya, Margarita Yatsunskaya, Elena Vasyutkina, Oksana Son, Liudmila Tekutyeva, Yury Shkryl, Engineered Fungus Thermothelomyces thermophilus Producing Plant Storage Proteins, 2022, 8, 2309-608X, 119, 10.3390/jof8020119
    14. Ji-Su Jun, Min-Joo Kim, KwangWon Hong, Novel sinIR promoter for Bacillus subtilis DB104 recombinant protein expression system, 2023, 66, 1976-0442, 10.3839/jabc.2023.019
    15. Mohtaram Mahmoudieh, Mohammad Reza Naghavi, Zulfazli M. Sobri, Azzreena Mohamad Azzeme, Nazrin Abd-Aziz, Nik Mohd Afizan Nik Abd Rahman, Noorjahan Banu Alitheen, Yazmin Hussin, Ghazaleh Bahmanrokh, Nadiya Akmal Baharum, Biotechnological approaches in the production of plant secondary metabolites for treating human viral diseases: Prospects and challenges, 2024, 59, 18788181, 103249, 10.1016/j.bcab.2024.103249
    16. Sezer Okay, 2024, Chapter 12, 978-1-0716-4062-3, 179, 10.1007/978-1-0716-4063-0_12
    17. Xiufang Liu, Mulin Lian, Mouming Zhao, Mingtao Huang, Advances in recombinant protease production: current state and perspectives, 2024, 40, 0959-3993, 10.1007/s11274-024-03957-5
    18. Nina Lautenschläger, Katja Schmidt, Carolin Schiffer, Thomas F. Wulff, Karin Hahnke, Knut Finstermeier, Moïse Mansour, Alexander K. W. Elsholz, Emmanuelle Charpentier, Expanding the genetic toolbox for the obligate human pathogen Streptococcus pyogenes, 2024, 12, 2296-4185, 10.3389/fbioe.2024.1395659
    19. Anastasiya N. Shishparenok, Yulia A. Gladilina, Dmitry D. Zhdanov, Engineering and Expression Strategies for Optimization of L-Asparaginase Development and Production, 2023, 24, 1422-0067, 15220, 10.3390/ijms242015220
    20. Hye Min Song, Seo Young Jo, Haeyoung Lee, Subeen Jeon, Dohye Yun, Chaerin Kim, Jina Son, Yu Jung Sohn, Jong-Il Choi, Si Jae Park, Recent advances on the systems metabolically engineered Pseudomonas species as versatile biosynthetic platforms for the production of polyhydroxyalkanoates, 2024, 4, 2662-7655, 473, 10.1007/s43393-023-00215-x
    21. Fatemeh Aziziyan, Farnoosh Farzam, Bahareh Dabirmanesh, Khosro Khajeh, 2024, 9780323918893, 25, 10.1016/B978-0-323-91889-3.00002-9
    22. Karla Pollyanna Vieira de Oliveira, Ana Lívia de Carvalho Bovolato, Silviene Novikoff, 2024, 9780443187674, 233, 10.1016/B978-0-443-18767-4.00019-6
    23. Abhilasha K. Rani, Richa Katiyar, Anurag S. Rathore, Bioprocessing of inclusion bodies from E. coli. to produce bioactive recombinant proteins, 2024, 203, 1369703X, 109188, 10.1016/j.bej.2023.109188
    24. Sara Ranjit, 2024, Design, Development and Comparison of Hybrid Approaches for DNA Promoter Identification, 979-8-3503-8269-3, 1, 10.1109/ICITEICS61368.2024.10625379
    25. Ming Liu, Ran Xiao, Xiaolin Li, Yingyu Zhao, Jihong Huang, A comprehensive review of recombinant technology in the food industry: Exploring expression systems, application, and future challenges, 2025, 24, 1541-4337, 10.1111/1541-4337.70078
  • Reader Comments
  • © 2020 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(15051) PDF downloads(2125) Cited by(25)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog